Medtech executives are poised to navigate a rapidly changing landscape towards 2026, shaped by three key trends:
-
Portfolio Re-construction: Companies are focusing investments on high-growth, high-margin therapeutic areas like pulsed field ablation and neuromodulation. This shift, along with strategic divestitures and acquisitions worth $32.6 billion, aims to enhance shareholder returns while optimizing operational costs.
-
Care Delivery Transformation: A significant shift is occurring as more complex procedures move from hospitals to ambulatory surgery centers (ASCs), expanding the market for ASC operators. Companies need to adapt their commercial strategies to meet the distinct needs of ASCs, which involve different cost structures and workflows compared to traditional hospitals.
-
AI and Data Governance: The integration of AI into operations is becoming essential for competitiveness, although challenges with data quality and regulatory compliance persist. Industry leaders are prioritizing foundational investments in data governance and talent to fully capitalize on AI’s potential.
In conclusion, medtech firms that strategically realign investments, adapt to new care delivery models, and build robust data capabilities will be better positioned for innovation and competitive success.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.deloitte.com/us/en/industries/life-sciences-health-care/blogs/health-care/three-key-trends-likely-to-shape-medtech.html
